FUJIFILM Biotechnologies Capacity Update – May 2026

Home | Knowledge Center | Resource Library | FUJIFILM Biotechnologies Capacity Update – May 2026

Progressing biological drug candidates from discovery to commercialization is a complex, cost-intensive process. FUJIFILM Biotechnologies has deep process development expertise combined with diverse manufacturing strategies, scales and sites for drug substance, drug product and finished goods. Together, within a harmonized kojoX™ network, these smooth the transition to clinical manufacture while de-risking commercialization and global supply.

Primary Interest(Required)
This field is hidden when viewing the form
Segments(Required)
This field is hidden when viewing the form
Sub-Segments(Required)
Privacy Policy(Required)
By submitting this form I agree that FUJIFILM Biotechnologies may process my data in the manner described in FUJIFILM’s Privacy Policy